GRI CIK: 1824293

GRI Bio, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−8.31
FY22:
−1.09
FY23:
−8.99
FY24:
−8.61
FY25:
−10.2
Change from FY21 to FY25
millions USD
FY21:
−3.84
FY22:
0.00
FY23:
−0.01
FY24:
0
FY25:
0.00
Change from FY21 to FY25
millions USD
FY21:
15.7
FY22:
1.01
FY23:
10.8
FY24:
11.8
FY25:
13.4
millions USD
FY21:
3.59
FY22:
−0.08
FY23:
1.80
FY24:
3.22
FY25:
3.20
(positive)
Change from FY21 to FY25
millions USD
FY21:
−8.31
FY22:
−1.09
FY23:
−9.00
FY24:
−8.61
FY25:
−10.2

All amounts in millions USD Data sources:SEC EDGARTwelve Data